129 related articles for article (PubMed ID: 12360174)
1. A new thrombolytic agent, monteplase, is independent of the plasminogen activator inhibitor in patients with acute myocardial infarction: initial results of the COmbining Monteplase with Angioplasty (COMA) trial.
Inoue T; Yaguchi I; Takayanagi K; Hayashi T; Morooka S; Eguchi Y
Am Heart J; 2002 Oct; 144(4):E5. PubMed ID: 12360174
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of monteplase in acute myocardial infarction as a powerful thrombolytic agent for pretreatment of coronary intervention.
Inoue T; Nishiki R; Kageyama M; Node K
Cardiovasc Drug Rev; 2004; 22(4):320-33. PubMed ID: 15592577
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of monteplase in acute myocardial infarction.
Inoue T; Nishiki R; Kageyama M; Node K
Am J Cardiovasc Drugs; 2005; 5(4):225-31. PubMed ID: 15984905
[TBL] [Abstract][Full Text] [Related]
4. Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction.
Barbash GI; Hod H; Roth A; Miller HI; Rath S; Zahav YH; Modan M; Zivelin A; Laniado S; Seligsohn U
Am J Cardiol; 1989 Dec; 64(19):1231-5. PubMed ID: 2511742
[TBL] [Abstract][Full Text] [Related]
5. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
[TBL] [Abstract][Full Text] [Related]
6. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.
Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators
N Engl J Med; 1997 Jun; 336(23):1621-8. PubMed ID: 9173270
[TBL] [Abstract][Full Text] [Related]
7. Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Labinaz M; Sketch MH; Stebbins AL; DeFranco AC; Holmes DR; Kleiman NS; Betriu A; Rutsch WR; Vahanian A; Topol EJ; Califf RM
Am J Cardiol; 1996 Dec; 78(12):1338-44. PubMed ID: 8970403
[TBL] [Abstract][Full Text] [Related]
8. Low-dose tissue plasminogen activator followed by planned rescue angioplasty reduces time to reperfusion for acute myocardial infarction treated at community hospitals.
Kimura K; Tsukahara K; Usui T; Okuda J; Kitamura Y; Kosuge M; Sano T; Tohyama S; Yamanaka O; Yoshii Y; Umemura S
Jpn Circ J; 2001 Oct; 65(10):901-6. PubMed ID: 11665796
[TBL] [Abstract][Full Text] [Related]
9. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
10. Association of plasma levels of activated protein C with recanalization of the infarct-related coronary artery after thrombolytic therapy in acute myocardial infarction.
Takazoe K; Ogawa H; Yasue H; Sakamoto T; Oshima S; Arai H; Moriyama Y; Shimomura H; Hirai N; Kaikita K; Soejima H; Misumi K; Hosoda K
Thromb Res; 1999 Jul; 95(1):37-47. PubMed ID: 10403685
[TBL] [Abstract][Full Text] [Related]
11. Accelerated plasminogen activator inhibitor may prevent late restenosis after coronary stenting in acute myocardial infarction.
Inoue T; Yaguchi I; Mizoguchi K; Uchida T; Takayanagi K; Hayashi T; Morooka S; Eguchi Y
Clin Cardiol; 2003 Mar; 26(3):153-7. PubMed ID: 12685623
[TBL] [Abstract][Full Text] [Related]
12. Serial changes of plasma plasminogen activator inhibitor activity in acute myocardial infarction: difference between thrombolytic therapy and direct coronary angioplasty.
Hirashima O; Ogawa H; Oshima S; Sakamoto T; Honda Y; Sakata S; Masuda T; Miyao Y; Yasue H
Am Heart J; 1995 Nov; 130(5):933-9. PubMed ID: 7484753
[TBL] [Abstract][Full Text] [Related]
13. Long-term benefits of monteplase before coronary angioplasty in acute myocardial infarction.
Inoue T; Nishiki R; Kageyama M; Chida R; Hayashi T; Takayanagi K; Hikichi Y; Node K
Am J Cardiol; 2005 Feb; 95(4):506-8. PubMed ID: 15695140
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the fibrinolytic system components during acute myocardial infarction.
Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
[TBL] [Abstract][Full Text] [Related]
15. Association of patency of the infarct-related coronary artery with plasma levels of plasminogen activator inhibitor activity in acute myocardial infarction.
Sakamoto T; Yasue H; Ogawa H; Misumi I; Masuda T
Am J Cardiol; 1992 Aug; 70(3):271-6. PubMed ID: 1632387
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of percutaneous coronary intervention with antecedent mutant t-PA administration for acute myocardial infarction.
Kurihara H; Matsumoto S; Tamura R; Yachiku K; Nakata A; Nakagawa T; Yoshino T; Matsuyama T
Am Heart J; 2004 Apr; 147(4):E14. PubMed ID: 15077097
[TBL] [Abstract][Full Text] [Related]
17. Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction.
Nordt TK; Moser M; Kohler B; Ruef J; Peter K; Kübler W; Bode C
Thromb Haemost; 1998 Dec; 80(6):881-6. PubMed ID: 9869154
[TBL] [Abstract][Full Text] [Related]
18. Serial changes in plasma concentration of plasminogen activator inhibitor-1 before and serially after thrombolytic therapy for acute myocardial infarction.
Goto S; Kawai Y; Handa S; Abe S; Takahashi E; Watanabe K; Hori S; Ikeda Y
Cardiology; 1993; 82(4):280-5. PubMed ID: 8402755
[TBL] [Abstract][Full Text] [Related]
19. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
[TBL] [Abstract][Full Text] [Related]
20. Plasma plasminogen activator inhibitor-1, tissue plasminogen activator and serum lipoprotein(a) after reperfusion therapy in acute myocardial infarction: comparison between sequential and direct percutaneous transluminal coronary angioplasty.
Hara M; Ito K; Nawata T; Tsunematsu Y; Shimoyama N; Maeda T; Sato Y; Saikawa T; Sakata T
Cardiology; 1995; 86(5):407-10. PubMed ID: 7585744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
